国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Business

Private equity heads for healthcare firms at 4 sites

By Cai Xiao | China Daily | Updated: 2014-04-29 09:00

Domestic private equity firm China Science and Merchants Capital Management Ltd will invest at least 30 billion yuan ($4.8 billion) in the nation's health industry within five years, its chairman said.

The funds will go into companies in industrial bases in Tianjin, Shanghai, Guangzhou and Huzhou in Zhejiang province that were set up by CSM Group and local governments.

"The supply of healthcare products and equipment in China can't satisfy the huge demand of the public, so there are many investment opportunities," said Shan Xiangshuang, chairman of CSM Group.

CSM Group and Healthcare UK have signed a memorandum of understanding to bring advanced medical technology and products from Britain to China. Healthcare UK is a joint initiative of the Department of Health, UK Trade and Investment and NHS England.

The two parties will introduce British healthcare companies to the industrial bases and innovation platforms of CSM Group. There were 11 innovation platforms to support startup enterprises in 2013, and that number will be 50 by the end of this year.

With more than 60 billion yuan under management, CSM Group has invested more than 10 billion yuan in more than 100 health-related enterprises, of which Xiangxue Pharmaceutical Co Ltd and Ringpu Bio-Pharmacy Co Ltd have been listed.

In 2009, CSM Group and China Securities Co Ltd invested 64 million yuan in Xiangxue, which went public on the ChiNext board in 2010. Ringpu received 48 million yuan from CSM Group in 2008 and went public on the ChiNext board in 2010.

Shan said that CSM Group is also investing in early-stage companies in the medical sector. For example, Micro-Tech received 4 million yuan from CSM Group when it was just starting up. Now, it's preparing to go public.

Private equity firms are seeking opportunities in China's health market. For instance, the Carlyle Group LP is setting up its fourth Asia-focused buyout fund for healthcare and consumer investments and China is its largest destination.

Warburg Pincus LLC, Fosun Group and CDH Investments were also active in the sector in 2013.

caixiao@chinadaily.com.cn

 

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
本溪| 辉南县| 西乌珠穆沁旗| 丹江口市| 灵璧县| 尚义县| 丹凤县| 于都县| 肃南| 湖南省| 绥芬河市| 太白县| 宿松县| 江孜县| 通州市| 绥阳县| 宝坻区| 通山县| 额敏县| 滕州市| 泸州市| 吉林市| 西林县| 富蕴县| 农安县| 莆田市| 大英县| 海晏县| 西青区| 葫芦岛市| 长葛市| 兴海县| SHOW| 宜黄县| 鄄城县| 巫溪县| 九寨沟县| 特克斯县| 晋城| 芮城县| 太仆寺旗|